rewirebio.iobenchmarks
Dataset

UNITE cross-validation set: shallow WGS plasma cfDNA, 458 healthy and 1,232 cancer samples

Pooled public and newly sequenced plasma sWGS data used for cross-validation in Wang et al. 2026.

Research readiness

These checks assess whether the evidence supports a reproducible investigation. A source-checked score alone does not meet these requirements.

Release 2026-10-10-7b8f80935f90 · Evidence verified: Not verified

Evidence incomplete

Replay metrics

Exact outcomes, predictions, identifiers and evaluator are connected.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • artifact hashes: verification is missing
  • join integrity: verification is missing
  • score semantics: verification is missing
  • metric replay: verification is missing

Verified: Not verified

Evidence incomplete

Investigate discrepancies

Replay evidence includes annotations and an assessment of dependence. Unknown independence permits descriptive analysis only.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • artifact hashes: verification is missing
  • join integrity: verification is missing
  • score semantics: verification is missing
  • metric replay: verification is missing
  • annotations: verification is missing
  • dependence: verification is missing

Verified: Not verified

Evidence incomplete

Run locally

A pinned recipe describes the inputs, environment and resource requirements.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • artifact hashes: verification is missing
  • join integrity: verification is missing
  • score semantics: verification is missing
  • recipe pinned: verification is missing
  • resource estimate: verification is missing

Verified: Not verified

Evidence incomplete

Validate independently

Separate data and exposure records support an independent test.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • artifact hashes: verification is missing
  • join integrity: verification is missing
  • score semantics: verification is missing
  • independent validation: verification is missing
  • overlap checked: verification is missing

Verified: Not verified

Readiness describes the evidence in this release. Availability on your computer is checked separately when an investigation runs. Existing data exposure can prevent independent validation even when files are available.

Artifacts and reproduction

No verified artifact manifest is connected to this record yet. The gaps above identify what is needed before analysis can begin.

Read reviewed discrepancy investigations

Evaluation results

28 evaluations · 193 results. Different protocols are not a single leaderboard.

Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: UNITE XGBoost, All five feature types (UNITE-XGB, model X6) (Wang et al. 2026)Protocol: UNITE cross-validation, cancers with ichorCNA tumour fraction 0 to 0.03 vs healthy (Wang et al. 2026)
Dataset: UNITE cross-validation set: shallow WGS plasma cfDNA, 458 healthy and 1,232 cancer samples
0.808 accuracy
fraction · higher

Uncertainty: 95% CI 0.802240119639737 to 0.814043033337814. Interval over the 50 outer test folds as printed in columns G and H

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

UNITE XGBoost All five feature types (UNITE-XGB, model X6), ichorCNA tumour fraction 0 to 0.03

ctdnafrag-20261009-protocol-wang2026-unite-cv-tf-0-3pct

Aggregation: Not reported

A scalable deep-learning framework for cancer detection using cell-free DNA shallow whole-genome sequencing; Wang et al. 2026, Data file S2 (model scores and summary statistics) · Data file S2 sheet STATS_xgb_x1-x6, row 7 (feat 'All', ichorcna_strat '[0, 0.03]', .metric 'Accuracy'), column D 'mean'
Configuration: UNITE XGBoost, All five feature types (UNITE-XGB, model X6) (Wang et al. 2026)Protocol: UNITE cross-validation, cancers with ichorCNA tumour fraction 0 to 0.03 vs healthy (Wang et al. 2026)
Dataset: UNITE cross-validation set: shallow WGS plasma cfDNA, 458 healthy and 1,232 cancer samples
0.922 auprc
unitless · higher

Uncertainty: 95% CI 0.916937208671138 to 0.926555712665032. Interval over the 50 outer test folds as printed in columns G and H

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

UNITE XGBoost All five feature types (UNITE-XGB, model X6), ichorCNA tumour fraction 0 to 0.03

ctdnafrag-20261009-protocol-wang2026-unite-cv-tf-0-3pct

Aggregation: Not reported

A scalable deep-learning framework for cancer detection using cell-free DNA shallow whole-genome sequencing; Wang et al. 2026, Data file S2 (model scores and summary statistics) · Data file S2 sheet STATS_xgb_x1-x6, row 3 (feat 'All', ichorcna_strat '[0, 0.03]', .metric 'AUPRC'), column D 'mean'
Configuration: UNITE XGBoost, All five feature types (UNITE-XGB, model X6) (Wang et al. 2026)Protocol: UNITE cross-validation, cancers with ichorCNA tumour fraction 0 to 0.03 vs healthy (Wang et al. 2026)
Dataset: UNITE cross-validation set: shallow WGS plasma cfDNA, 458 healthy and 1,232 cancer samples
0.878 auroc
unitless · higher

Uncertainty: 95% CI 0.871088518357102 to 0.884027033099431. Interval over the 50 outer test folds as printed in columns G and H

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

UNITE XGBoost All five feature types (UNITE-XGB, model X6), ichorCNA tumour fraction 0 to 0.03

ctdnafrag-20261009-protocol-wang2026-unite-cv-tf-0-3pct

Aggregation: Not reported

A scalable deep-learning framework for cancer detection using cell-free DNA shallow whole-genome sequencing; Wang et al. 2026, Data file S2 (model scores and summary statistics) · Data file S2 sheet STATS_xgb_x1-x6, row 2 (feat 'All', ichorcna_strat '[0, 0.03]', .metric 'AUROC'), column D 'mean'
Configuration: UNITE XGBoost, All five feature types (UNITE-XGB, model X6) (Wang et al. 2026)Protocol: UNITE cross-validation, cancers with ichorCNA tumour fraction 0 to 0.03 vs healthy (Wang et al. 2026)
Dataset: UNITE cross-validation set: shallow WGS plasma cfDNA, 458 healthy and 1,232 cancer samples
0.845 f1-score
fraction · higher

Uncertainty: 95% CI 0.839539847060346 to 0.850016168231015. Interval over the 50 outer test folds as printed in columns G and H

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

UNITE XGBoost All five feature types (UNITE-XGB, model X6), ichorCNA tumour fraction 0 to 0.03

ctdnafrag-20261009-protocol-wang2026-unite-cv-tf-0-3pct

Aggregation: Not reported

A scalable deep-learning framework for cancer detection using cell-free DNA shallow whole-genome sequencing; Wang et al. 2026, Data file S2 (model scores and summary statistics) · Data file S2 sheet STATS_xgb_x1-x6, row 6 (feat 'All', ichorcna_strat '[0, 0.03]', .metric 'F1'), column D 'mean'
Configuration: UNITE XGBoost, All five feature types (UNITE-XGB, model X6) (Wang et al. 2026)Protocol: UNITE cross-validation, cancers with ichorCNA tumour fraction 0 to 0.03 vs healthy (Wang et al. 2026)
Dataset: UNITE cross-validation set: shallow WGS plasma cfDNA, 458 healthy and 1,232 cancer samples
0.841 recall
fraction · higher

Uncertainty: 95% CI 0.832242583740728 to 0.848880621293709. Interval over the 50 outer test folds as printed in columns G and H

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

UNITE XGBoost All five feature types (UNITE-XGB, model X6), ichorCNA tumour fraction 0 to 0.03

ctdnafrag-20261009-protocol-wang2026-unite-cv-tf-0-3pct

Aggregation: Not reported

A scalable deep-learning framework for cancer detection using cell-free DNA shallow whole-genome sequencing; Wang et al. 2026, Data file S2 (model scores and summary statistics) · Data file S2 sheet STATS_xgb_x1-x6, row 4 (feat 'All', ichorcna_strat '[0, 0.03]', .metric 'Sensitivity'), column D 'mean'
Configuration: UNITE XGBoost, All five feature types (UNITE-XGB, model X6) (Wang et al. 2026)Protocol: UNITE cross-validation, cancers with ichorCNA tumour fraction 0 to 0.03 vs healthy (Wang et al. 2026)
Dataset: UNITE cross-validation set: shallow WGS plasma cfDNA, 458 healthy and 1,232 cancer samples
0.754 specificity
fraction · higher

Uncertainty: 95% CI 0.742458347688347 to 0.764656413577121. Interval over the 50 outer test folds as printed in columns G and H

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

UNITE XGBoost All five feature types (UNITE-XGB, model X6), ichorCNA tumour fraction 0 to 0.03

ctdnafrag-20261009-protocol-wang2026-unite-cv-tf-0-3pct

Aggregation: Not reported

A scalable deep-learning framework for cancer detection using cell-free DNA shallow whole-genome sequencing; Wang et al. 2026, Data file S2 (model scores and summary statistics) · Data file S2 sheet STATS_xgb_x1-x6, row 5 (feat 'All', ichorcna_strat '[0, 0.03]', .metric 'Specificity'), column D 'mean'
Configuration: UNITE XGBoost, All five feature types (UNITE-XGB, model X6) (Wang et al. 2026)Protocol: UNITE cross-validation, cancers with ichorCNA tumour fraction above 0.03 to 0.1 vs healthy (Wang et al. 2026)
Dataset: UNITE cross-validation set: shallow WGS plasma cfDNA, 458 healthy and 1,232 cancer samples
0.922 accuracy
fraction · higher

Uncertainty: 95% CI 0.915937876140555 to 0.927509270044652. Interval over the 50 outer test folds as printed in columns G and H

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

UNITE XGBoost All five feature types (UNITE-XGB, model X6), ichorCNA tumour fraction above 0.03 to 0.1

ctdnafrag-20261009-protocol-wang2026-unite-cv-tf-3-10pct

Aggregation: Not reported

A scalable deep-learning framework for cancer detection using cell-free DNA shallow whole-genome sequencing; Wang et al. 2026, Data file S2 (model scores and summary statistics) · Data file S2 sheet STATS_xgb_x1-x6, row 43 (feat 'All', ichorcna_strat '(0.03, 0.1]', .metric 'Accuracy'), column D 'mean'
Configuration: UNITE XGBoost, All five feature types (UNITE-XGB, model X6) (Wang et al. 2026)Protocol: UNITE cross-validation, cancers with ichorCNA tumour fraction above 0.03 to 0.1 vs healthy (Wang et al. 2026)
Dataset: UNITE cross-validation set: shallow WGS plasma cfDNA, 458 healthy and 1,232 cancer samples
0.952 auprc
unitless · higher

Uncertainty: 95% CI 0.946540275378965 to 0.957277248648428. Interval over the 50 outer test folds as printed in columns G and H

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

UNITE XGBoost All five feature types (UNITE-XGB, model X6), ichorCNA tumour fraction above 0.03 to 0.1

ctdnafrag-20261009-protocol-wang2026-unite-cv-tf-3-10pct

Aggregation: Not reported

A scalable deep-learning framework for cancer detection using cell-free DNA shallow whole-genome sequencing; Wang et al. 2026, Data file S2 (model scores and summary statistics) · Data file S2 sheet STATS_xgb_x1-x6, row 39 (feat 'All', ichorcna_strat '(0.03, 0.1]', .metric 'AUPRC'), column D 'mean'
Configuration: UNITE XGBoost, All five feature types (UNITE-XGB, model X6) (Wang et al. 2026)Protocol: UNITE cross-validation, cancers with ichorCNA tumour fraction above 0.03 to 0.1 vs healthy (Wang et al. 2026)
Dataset: UNITE cross-validation set: shallow WGS plasma cfDNA, 458 healthy and 1,232 cancer samples
0.962 auroc
unitless · higher

Uncertainty: 95% CI 0.956864305379267 to 0.965835559427218. Interval over the 50 outer test folds as printed in columns G and H

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

UNITE XGBoost All five feature types (UNITE-XGB, model X6), ichorCNA tumour fraction above 0.03 to 0.1

ctdnafrag-20261009-protocol-wang2026-unite-cv-tf-3-10pct

Aggregation: Not reported

A scalable deep-learning framework for cancer detection using cell-free DNA shallow whole-genome sequencing; Wang et al. 2026, Data file S2 (model scores and summary statistics) · Data file S2 sheet STATS_xgb_x1-x6, row 38 (feat 'All', ichorcna_strat '(0.03, 0.1]', .metric 'AUROC'), column D 'mean'
Configuration: UNITE XGBoost, All five feature types (UNITE-XGB, model X6) (Wang et al. 2026)Protocol: UNITE cross-validation, cancers with ichorCNA tumour fraction above 0.03 to 0.1 vs healthy (Wang et al. 2026)
Dataset: UNITE cross-validation set: shallow WGS plasma cfDNA, 458 healthy and 1,232 cancer samples
0.886 f1-score
fraction · higher

Uncertainty: 95% CI 0.876606186107664 to 0.894600007080721. Interval over the 50 outer test folds as printed in columns G and H

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

UNITE XGBoost All five feature types (UNITE-XGB, model X6), ichorCNA tumour fraction above 0.03 to 0.1

ctdnafrag-20261009-protocol-wang2026-unite-cv-tf-3-10pct

Aggregation: Not reported

A scalable deep-learning framework for cancer detection using cell-free DNA shallow whole-genome sequencing; Wang et al. 2026, Data file S2 (model scores and summary statistics) · Data file S2 sheet STATS_xgb_x1-x6, row 42 (feat 'All', ichorcna_strat '(0.03, 0.1]', .metric 'F1'), column D 'mean'
Configuration: UNITE XGBoost, All five feature types (UNITE-XGB, model X6) (Wang et al. 2026)Protocol: UNITE cross-validation, cancers with ichorCNA tumour fraction above 0.03 to 0.1 vs healthy (Wang et al. 2026)
Dataset: UNITE cross-validation set: shallow WGS plasma cfDNA, 458 healthy and 1,232 cancer samples
0.85 recall
fraction · higher

Uncertainty: 95% CI 0.835385112660256 to 0.863737766561006. Interval over the 50 outer test folds as printed in columns G and H

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

UNITE XGBoost All five feature types (UNITE-XGB, model X6), ichorCNA tumour fraction above 0.03 to 0.1

ctdnafrag-20261009-protocol-wang2026-unite-cv-tf-3-10pct

Aggregation: Not reported

A scalable deep-learning framework for cancer detection using cell-free DNA shallow whole-genome sequencing; Wang et al. 2026, Data file S2 (model scores and summary statistics) · Data file S2 sheet STATS_xgb_x1-x6, row 40 (feat 'All', ichorcna_strat '(0.03, 0.1]', .metric 'Sensitivity'), column D 'mean'
Configuration: UNITE XGBoost, All five feature types (UNITE-XGB, model X6) (Wang et al. 2026)Protocol: UNITE cross-validation, cancers with ichorCNA tumour fraction above 0.03 to 0.1 vs healthy (Wang et al. 2026)
Dataset: UNITE cross-validation set: shallow WGS plasma cfDNA, 458 healthy and 1,232 cancer samples
0.962 specificity
fraction · higher

Uncertainty: 95% CI 0.956435237452299 to 0.968120572709345. Interval over the 50 outer test folds as printed in columns G and H

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

UNITE XGBoost All five feature types (UNITE-XGB, model X6), ichorCNA tumour fraction above 0.03 to 0.1

ctdnafrag-20261009-protocol-wang2026-unite-cv-tf-3-10pct

Aggregation: Not reported

A scalable deep-learning framework for cancer detection using cell-free DNA shallow whole-genome sequencing; Wang et al. 2026, Data file S2 (model scores and summary statistics) · Data file S2 sheet STATS_xgb_x1-x6, row 41 (feat 'All', ichorcna_strat '(0.03, 0.1]', .metric 'Specificity'), column D 'mean'
Configuration: UNITE XGBoost, All five feature types (UNITE-XGB, model X6) (Wang et al. 2026)Protocol: UNITE cross-validation, cancers with all tumour fractions vs healthy (Wang et al. 2026)
Dataset: UNITE cross-validation set: shallow WGS plasma cfDNA, 458 healthy and 1,232 cancer samples
0.852 accuracy
fraction · higher

Uncertainty: 95% CI 0.847567448340331 to 0.857161440034147. Interval over the 50 outer test folds as printed in columns G and H

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

UNITE XGBoost All five feature types (UNITE-XGB, model X6), all tumour fractions

ctdnafrag-20261009-protocol-wang2026-unite-cv-tf-all

Aggregation: Not reported

A scalable deep-learning framework for cancer detection using cell-free DNA shallow whole-genome sequencing; Wang et al. 2026, Data file S2 (model scores and summary statistics) · Data file S2 sheet STATS_xgb_x1-x6, row 115 (feat 'All', ichorcna_strat 'all', .metric 'Accuracy'), column D 'mean'
Configuration: UNITE XGBoost, All five feature types (UNITE-XGB, model X6) (Wang et al. 2026)Protocol: UNITE cross-validation, cancers with all tumour fractions vs healthy (Wang et al. 2026)
Dataset: UNITE cross-validation set: shallow WGS plasma cfDNA, 458 healthy and 1,232 cancer samples
0.97 auprc
unitless · higher

Uncertainty: 95% CI 0.968264347567679 to 0.971522552495379. Interval over the 50 outer test folds as printed in columns G and H

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

UNITE XGBoost All five feature types (UNITE-XGB, model X6), all tumour fractions

ctdnafrag-20261009-protocol-wang2026-unite-cv-tf-all

Aggregation: Not reported

A scalable deep-learning framework for cancer detection using cell-free DNA shallow whole-genome sequencing; Wang et al. 2026, Data file S2 (model scores and summary statistics) · Data file S2 sheet STATS_xgb_x1-x6, row 111 (feat 'All', ichorcna_strat 'all', .metric 'AUPRC'), column D 'mean'
Configuration: UNITE XGBoost, All five feature types (UNITE-XGB, model X6) (Wang et al. 2026)Protocol: UNITE cross-validation, cancers with all tumour fractions vs healthy (Wang et al. 2026)
Dataset: UNITE cross-validation set: shallow WGS plasma cfDNA, 458 healthy and 1,232 cancer samples
0.916 auroc
unitless · higher

Uncertainty: 95% CI 0.912077380234279 to 0.919242513352284. Interval over the 50 outer test folds as printed in columns G and H

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

UNITE XGBoost All five feature types (UNITE-XGB, model X6), all tumour fractions

ctdnafrag-20261009-protocol-wang2026-unite-cv-tf-all

Aggregation: Not reported

A scalable deep-learning framework for cancer detection using cell-free DNA shallow whole-genome sequencing; Wang et al. 2026, Data file S2 (model scores and summary statistics) · Data file S2 sheet STATS_xgb_x1-x6, row 110 (feat 'All', ichorcna_strat 'all', .metric 'AUROC'), column D 'mean'
Configuration: UNITE XGBoost, All five feature types (UNITE-XGB, model X6) (Wang et al. 2026)Protocol: UNITE cross-validation, cancers with all tumour fractions vs healthy (Wang et al. 2026)
Dataset: UNITE cross-validation set: shallow WGS plasma cfDNA, 458 healthy and 1,232 cancer samples
0.898 f1-score
fraction · higher

Uncertainty: 95% CI 0.894147470612093 to 0.901005064645811. Interval over the 50 outer test folds as printed in columns G and H

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

UNITE XGBoost All five feature types (UNITE-XGB, model X6), all tumour fractions

ctdnafrag-20261009-protocol-wang2026-unite-cv-tf-all

Aggregation: Not reported

A scalable deep-learning framework for cancer detection using cell-free DNA shallow whole-genome sequencing; Wang et al. 2026, Data file S2 (model scores and summary statistics) · Data file S2 sheet STATS_xgb_x1-x6, row 114 (feat 'All', ichorcna_strat 'all', .metric 'F1'), column D 'mean'
Configuration: UNITE XGBoost, All five feature types (UNITE-XGB, model X6) (Wang et al. 2026)Protocol: UNITE cross-validation, cancers with all tumour fractions vs healthy (Wang et al. 2026)
Dataset: UNITE cross-validation set: shallow WGS plasma cfDNA, 458 healthy and 1,232 cancer samples
0.879 recall
fraction · higher

Uncertainty: 95% CI 0.872041210173299 to 0.885717327526083. Interval over the 50 outer test folds as printed in columns G and H

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

UNITE XGBoost All five feature types (UNITE-XGB, model X6), all tumour fractions

ctdnafrag-20261009-protocol-wang2026-unite-cv-tf-all

Aggregation: Not reported

A scalable deep-learning framework for cancer detection using cell-free DNA shallow whole-genome sequencing; Wang et al. 2026, Data file S2 (model scores and summary statistics) · Data file S2 sheet STATS_xgb_x1-x6, row 112 (feat 'All', ichorcna_strat 'all', .metric 'Sensitivity'), column D 'mean'
Configuration: UNITE XGBoost, All five feature types (UNITE-XGB, model X6) (Wang et al. 2026)Protocol: UNITE cross-validation, cancers with all tumour fractions vs healthy (Wang et al. 2026)
Dataset: UNITE cross-validation set: shallow WGS plasma cfDNA, 458 healthy and 1,232 cancer samples
0.779 specificity
fraction · higher

Uncertainty: 95% CI 0.767944094467296 to 0.791742927566671. Interval over the 50 outer test folds as printed in columns G and H

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

UNITE XGBoost All five feature types (UNITE-XGB, model X6), all tumour fractions

ctdnafrag-20261009-protocol-wang2026-unite-cv-tf-all

Aggregation: Not reported

A scalable deep-learning framework for cancer detection using cell-free DNA shallow whole-genome sequencing; Wang et al. 2026, Data file S2 (model scores and summary statistics) · Data file S2 sheet STATS_xgb_x1-x6, row 113 (feat 'All', ichorcna_strat 'all', .metric 'Specificity'), column D 'mean'
Configuration: UNITE XGBoost, All five feature types (UNITE-XGB, model X6) (Wang et al. 2026)Protocol: UNITE cross-validation, cancers with ichorCNA tumour fraction above 0.1 vs healthy (Wang et al. 2026)
Dataset: UNITE cross-validation set: shallow WGS plasma cfDNA, 458 healthy and 1,232 cancer samples
0.984 accuracy
fraction · higher

Uncertainty: 95% CI 0.98116327437065 to 0.987107461013067. Interval over the 50 outer test folds as printed in columns G and H

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

UNITE XGBoost All five feature types (UNITE-XGB, model X6), ichorCNA tumour fraction above 0.1

ctdnafrag-20261009-protocol-wang2026-unite-cv-tf-over-10pct

Aggregation: Not reported

A scalable deep-learning framework for cancer detection using cell-free DNA shallow whole-genome sequencing; Wang et al. 2026, Data file S2 (model scores and summary statistics) · Data file S2 sheet STATS_xgb_x1-x6, row 79 (feat 'All', ichorcna_strat '(0.1, 1]', .metric 'Accuracy'), column D 'mean'
Configuration: UNITE XGBoost, All five feature types (UNITE-XGB, model X6) (Wang et al. 2026)Protocol: UNITE cross-validation, cancers with ichorCNA tumour fraction above 0.1 vs healthy (Wang et al. 2026)
Dataset: UNITE cross-validation set: shallow WGS plasma cfDNA, 458 healthy and 1,232 cancer samples
0.997 auprc
unitless · higher

Uncertainty: 95% CI 0.996006106960816 to 0.998084845479669. Interval over the 50 outer test folds as printed in columns G and H

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

UNITE XGBoost All five feature types (UNITE-XGB, model X6), ichorCNA tumour fraction above 0.1

ctdnafrag-20261009-protocol-wang2026-unite-cv-tf-over-10pct

Aggregation: Not reported

A scalable deep-learning framework for cancer detection using cell-free DNA shallow whole-genome sequencing; Wang et al. 2026, Data file S2 (model scores and summary statistics) · Data file S2 sheet STATS_xgb_x1-x6, row 75 (feat 'All', ichorcna_strat '(0.1, 1]', .metric 'AUPRC'), column D 'mean'
Configuration: UNITE XGBoost, All five feature types (UNITE-XGB, model X6) (Wang et al. 2026)Protocol: UNITE cross-validation, cancers with ichorCNA tumour fraction above 0.1 vs healthy (Wang et al. 2026)
Dataset: UNITE cross-validation set: shallow WGS plasma cfDNA, 458 healthy and 1,232 cancer samples
0.998 auroc
unitless · higher

Uncertainty: 95% CI 0.997098449739814 to 0.99862092981655. Interval over the 50 outer test folds as printed in columns G and H

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

UNITE XGBoost All five feature types (UNITE-XGB, model X6), ichorCNA tumour fraction above 0.1

ctdnafrag-20261009-protocol-wang2026-unite-cv-tf-over-10pct

Aggregation: Not reported

A scalable deep-learning framework for cancer detection using cell-free DNA shallow whole-genome sequencing; Wang et al. 2026, Data file S2 (model scores and summary statistics) · Data file S2 sheet STATS_xgb_x1-x6, row 74 (feat 'All', ichorcna_strat '(0.1, 1]', .metric 'AUROC'), column D 'mean'
Configuration: UNITE XGBoost, All five feature types (UNITE-XGB, model X6) (Wang et al. 2026)Protocol: UNITE cross-validation, cancers with ichorCNA tumour fraction above 0.1 vs healthy (Wang et al. 2026)
Dataset: UNITE cross-validation set: shallow WGS plasma cfDNA, 458 healthy and 1,232 cancer samples
0.978 f1-score
fraction · higher

Uncertainty: 95% CI 0.974268340402816 to 0.98223292480869. Interval over the 50 outer test folds as printed in columns G and H

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

UNITE XGBoost All five feature types (UNITE-XGB, model X6), ichorCNA tumour fraction above 0.1

ctdnafrag-20261009-protocol-wang2026-unite-cv-tf-over-10pct

Aggregation: Not reported

A scalable deep-learning framework for cancer detection using cell-free DNA shallow whole-genome sequencing; Wang et al. 2026, Data file S2 (model scores and summary statistics) · Data file S2 sheet STATS_xgb_x1-x6, row 78 (feat 'All', ichorcna_strat '(0.1, 1]', .metric 'F1'), column D 'mean'
Configuration: UNITE XGBoost, All five feature types (UNITE-XGB, model X6) (Wang et al. 2026)Protocol: UNITE cross-validation, cancers with ichorCNA tumour fraction above 0.1 vs healthy (Wang et al. 2026)
Dataset: UNITE cross-validation set: shallow WGS plasma cfDNA, 458 healthy and 1,232 cancer samples
0.964 recall
fraction · higher

Uncertainty: 95% CI 0.956687062702704 to 0.971843551863538. Interval over the 50 outer test folds as printed in columns G and H

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

UNITE XGBoost All five feature types (UNITE-XGB, model X6), ichorCNA tumour fraction above 0.1

ctdnafrag-20261009-protocol-wang2026-unite-cv-tf-over-10pct

Aggregation: Not reported

A scalable deep-learning framework for cancer detection using cell-free DNA shallow whole-genome sequencing; Wang et al. 2026, Data file S2 (model scores and summary statistics) · Data file S2 sheet STATS_xgb_x1-x6, row 76 (feat 'All', ichorcna_strat '(0.1, 1]', .metric 'Sensitivity'), column D 'mean'
Configuration: UNITE XGBoost, All five feature types (UNITE-XGB, model X6) (Wang et al. 2026)Protocol: UNITE cross-validation, cancers with ichorCNA tumour fraction above 0.1 vs healthy (Wang et al. 2026)
Dataset: UNITE cross-validation set: shallow WGS plasma cfDNA, 458 healthy and 1,232 cancer samples
0.996 specificity
fraction · higher

Uncertainty: 95% CI 0.993627598409234 to 0.998498620004266. Interval over the 50 outer test folds as printed in columns G and H

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

UNITE XGBoost All five feature types (UNITE-XGB, model X6), ichorCNA tumour fraction above 0.1

ctdnafrag-20261009-protocol-wang2026-unite-cv-tf-over-10pct

Aggregation: Not reported

A scalable deep-learning framework for cancer detection using cell-free DNA shallow whole-genome sequencing; Wang et al. 2026, Data file S2 (model scores and summary statistics) · Data file S2 sheet STATS_xgb_x1-x6, row 77 (feat 'All', ichorcna_strat '(0.1, 1]', .metric 'Specificity'), column D 'mean'
Configuration: UNITE XGBoost, Copy number aberration (CNA) (Wang et al. 2026)Protocol: UNITE cross-validation, cancers with ichorCNA tumour fraction 0 to 0.03 vs healthy (Wang et al. 2026)
Dataset: UNITE cross-validation set: shallow WGS plasma cfDNA, 458 healthy and 1,232 cancer samples
0.686 accuracy
fraction · higher

Uncertainty: 95% CI 0.677782380024197 to 0.693932114531523. Interval over the 50 outer test folds as printed in columns G and H

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

UNITE XGBoost Copy number aberration (CNA), ichorCNA tumour fraction 0 to 0.03

ctdnafrag-20261009-protocol-wang2026-unite-cv-tf-0-3pct

Aggregation: Not reported

A scalable deep-learning framework for cancer detection using cell-free DNA shallow whole-genome sequencing; Wang et al. 2026, Data file S2 (model scores and summary statistics) · Data file S2 sheet STATS_xgb_x1-x6, row 25 (feat 'CNV', ichorcna_strat '[0, 0.03]', .metric 'Accuracy'), column D 'mean'

Source checking is not independent reproduction. Release 2026-10-10-7b8f80935f90.

Dataset and evaluation context

A dataset supplies biological observations. The evaluation protocol defines how those observations are split, used and scored.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

9 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-10-10-7b8f80935f90
Property and statementOriginal source and locationReview and provenance
attributes.assay
Plasma cfDNA shallow whole-genome sequencing, downsampled to 0.1x
Context-only references
A scalable deep-learning framework for cancer detection using cell-free DNA shallow whole-genome sequencing

Original source ↗

Wang et al. 2026 Introduction P5; Results P6, P9, P12; Methods P39-P40; Fig. 2 legend

Version: Science Advances 12(28):eady9432, published 2026-07-10; PMC13353424 full-text XML
Retrieved: 2026-10-09T20:27:02Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.assay

Source artifact SHA-256: 61464a274501bb9529b2250eb4c112071b8768fa640e87cf13f14d7df9f6fb23

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

attributes.population
1,690 plasma samples after quality control (458 healthy, 1,232 cancer from 26 types) pooled from new LUCID and OV04 data, EGA and FinaleDB, including the Cristiano et al. 2019 cohort; split 70:30 by study, cancer type and TF stratum into 1,237 cross-validation and 453 held-out samples. Cancers stratified by ichorCNA tumour fraction: [0, 0.03] 736, (0.03, 0.1] 239, (0.1, 0.2] 121, (0.2, 1] 136.
Context-only references
A scalable deep-learning framework for cancer detection using cell-free DNA shallow whole-genome sequencing

Original source ↗

Wang et al. 2026 Introduction P5; Results P6, P9, P12; Methods P39-P40; Fig. 2 legend

Version: Science Advances 12(28):eady9432, published 2026-07-10; PMC13353424 full-text XML
Retrieved: 2026-10-09T20:27:02Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.population

Source artifact SHA-256: 61464a274501bb9529b2250eb4c112071b8768fa640e87cf13f14d7df9f6fb23

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

attributes.scope_note
The cross-validation set (Data file S1, sheet s13, split 'cv') draws 352 samples (182 healthy, 170 cancer) from the Cristiano et al. 2019 FinaleDB data, the cohort of amp-20261007-ctdna-fragmentomics-dataset and of the Hou et al. 2024 cross-validation, and 86 samples (23 healthy, 63 hepatocellular carcinoma) from the Jiang et al. FinaleDB data (labelled 'Jiang et al, 2015'), the same 225-sample composition as ctdnafrag-20261009-data-hou2024-jiang2018-lihc. Which individual samples are shared with those records cannot be told from the published tables.
Context-only references
A scalable deep-learning framework for cancer detection using cell-free DNA shallow whole-genome sequencing

Original source ↗

Wang et al. 2026 Introduction P5; Results P6, P9, P12; Methods P39-P40; Fig. 2 legend

Version: Science Advances 12(28):eady9432, published 2026-07-10; PMC13353424 full-text XML
Retrieved: 2026-10-09T20:27:02Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.scope_note

Source artifact SHA-256: 61464a274501bb9529b2250eb4c112071b8768fa640e87cf13f14d7df9f6fb23

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

attributes.source_locator
Wang et al. 2026 Introduction P5; Results P6, P9, P12; Methods P39-P40; Fig. 2 legend
Context-only references
A scalable deep-learning framework for cancer detection using cell-free DNA shallow whole-genome sequencing

Original source ↗

Wang et al. 2026 Introduction P5; Results P6, P9, P12; Methods P39-P40; Fig. 2 legend

Version: Science Advances 12(28):eady9432, published 2026-07-10; PMC13353424 full-text XML
Retrieved: 2026-10-09T20:27:02Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.source_locator

Source artifact SHA-256: 61464a274501bb9529b2250eb4c112071b8768fa640e87cf13f14d7df9f6fb23

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

attributes.split
1,237 cross-validation samples; 5-fold cross-validation repeated 10 times within them
Context-only references
A scalable deep-learning framework for cancer detection using cell-free DNA shallow whole-genome sequencing

Original source ↗

Wang et al. 2026 Introduction P5; Results P6, P9, P12; Methods P39-P40; Fig. 2 legend

Version: Science Advances 12(28):eady9432, published 2026-07-10; PMC13353424 full-text XML
Retrieved: 2026-10-09T20:27:02Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.split

Source artifact SHA-256: 61464a274501bb9529b2250eb4c112071b8768fa640e87cf13f14d7df9f6fb23

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

attributes.total
1690
Context-only references
A scalable deep-learning framework for cancer detection using cell-free DNA shallow whole-genome sequencing

Original source ↗

Wang et al. 2026 Introduction P5; Results P6, P9, P12; Methods P39-P40; Fig. 2 legend

Version: Science Advances 12(28):eady9432, published 2026-07-10; PMC13353424 full-text XML
Retrieved: 2026-10-09T20:27:02Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.total

Source artifact SHA-256: 61464a274501bb9529b2250eb4c112071b8768fa640e87cf13f14d7df9f6fb23

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

attributes.version
Wang et al. 2026 (Science Advances 12:eady9432) sample selection
Context-only references
A scalable deep-learning framework for cancer detection using cell-free DNA shallow whole-genome sequencing

Original source ↗

Wang et al. 2026 Introduction P5; Results P6, P9, P12; Methods P39-P40; Fig. 2 legend

Version: Science Advances 12(28):eady9432, published 2026-07-10; PMC13353424 full-text XML
Retrieved: 2026-10-09T20:27:02Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.version

Source artifact SHA-256: 61464a274501bb9529b2250eb4c112071b8768fa640e87cf13f14d7df9f6fb23

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

description
Pooled public and newly sequenced plasma sWGS data used for cross-validation in Wang et al. 2026.
Context-only references
A scalable deep-learning framework for cancer detection using cell-free DNA shallow whole-genome sequencing

Original source ↗

Wang et al. 2026 Introduction P5; Results P6, P9, P12; Methods P39-P40; Fig. 2 legend

Version: Science Advances 12(28):eady9432, published 2026-07-10; PMC13353424 full-text XML
Retrieved: 2026-10-09T20:27:02Z

not individually reviewed

No individual claim review recorded

Audit details

Field: description

Source artifact SHA-256: 61464a274501bb9529b2250eb4c112071b8768fa640e87cf13f14d7df9f6fb23

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

name
UNITE cross-validation set: shallow WGS plasma cfDNA, 458 healthy and 1,232 cancer samples
Context-only references
A scalable deep-learning framework for cancer detection using cell-free DNA shallow whole-genome sequencing

Original source ↗

Wang et al. 2026 Introduction P5; Results P6, P9, P12; Methods P39-P40; Fig. 2 legend

Version: Science Advances 12(28):eady9432, published 2026-07-10; PMC13353424 full-text XML
Retrieved: 2026-10-09T20:27:02Z

not individually reviewed

No individual claim review recorded

Audit details

Field: name

Source artifact SHA-256: 61464a274501bb9529b2250eb4c112071b8768fa640e87cf13f14d7df9f6fb23

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Sources and history

Release 2026-10-10-7b8f80935f90 · Record review: source checked

1 source records and release historyDownload this release (gzip)
Technical metadata and extraction receipts

Stable ID: ctdnafrag-20261009-data-wang2026-unite-cross-validation

areas
dna-genomes
contexts
clinical_research
version
Wang et al. 2026 (Science Advances 12:eady9432) sample selection
population
1,690 plasma samples after quality control (458 healthy, 1,232 cancer from 26 types) pooled from new LUCID and OV04 data, EGA and FinaleDB, including the Cristiano et al. 2019 cohort; split 70:30 by study, cancer type and TF stratum into 1,237 cross-validation and 453 held-out samples. Cancers stratified by ichorCNA tumour fraction: [0, 0.03] 736, (0.03, 0.1] 239, (0.1, 0.2] 121, (0.2, 1] 136.
split
1,237 cross-validation samples; 5-fold cross-validation repeated 10 times within them
total
1690
assay
Plasma cfDNA shallow whole-genome sequencing, downsampled to 0.1x
scope note
The cross-validation set (Data file S1, sheet s13, split 'cv') draws 352 samples (182 healthy, 170 cancer) from the Cristiano et al. 2019 FinaleDB data, the cohort of amp-20261007-ctdna-fragmentomics-dataset and of the Hou et al. 2024 cross-validation, and 86 samples (23 healthy, 63 hepatocellular carcinoma) from the Jiang et al. FinaleDB data (labelled 'Jiang et al, 2015'), the same 225-sample composition as ctdnafrag-20261009-data-hou2024-jiang2018-lihc. Which individual samples are shared with those records cannot be told from the published tables.
source locator
Wang et al. 2026 Introduction P5; Results P6, P9, P12; Methods P39-P40; Fig. 2 legend
Related records

Suggest a correction